Tags

Type your tag names separated by a space and hit enter

Coronavirus 2019-nCoV: A brief perspective from the front line.
J Infect. 2020 04; 80(4):373-377.JI

Abstract

A novel coronavirus, designated as 2019-nCoV, hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of China and multiple countries. As of 0:00 am February 9, 2020, a total of 37,287 cases have been confirmed infection of 2019-nCoV in China mainland, and 302 cases have also been cumulatively reported from 24 countries. According to the latest data, a total of 813 deaths occurred in China mainland, with the mortality reaching approximately 2.2%. At present, there is no vaccine or specific drugs for the human coronavirus. Therefore, it is critical to understand the nature of the virus and its clinical characteristics, in order to respond to the 2019-nCoV outbreak. Thus, the present study briefly but comprehensively summarizes the not much but timely reports on the 2019-nCoV.

Authors+Show Affiliations

Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, 79# Qingchun Road, Hangzhou 310003, Zhejiang, People's Republic of China; Malignant Lymphoma Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, People's Republic of China; Institute of Hematology, Zhejiang University, Hangzhou 31003, Zhejiang, People's Republic of China.Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, 79# Qingchun Road, Hangzhou 310003, Zhejiang, People's Republic of China; Malignant Lymphoma Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, People's Republic of China; Institute of Hematology, Zhejiang University, Hangzhou 31003, Zhejiang, People's Republic of China.Department of Hematology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang, People's Republic of China.Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, 79# Qingchun Road, Hangzhou 310003, Zhejiang, People's Republic of China; Malignant Lymphoma Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, People's Republic of China; Institute of Hematology, Zhejiang University, Hangzhou 31003, Zhejiang, People's Republic of China. Electronic address: youliangshun@zju.edu.cn.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

32109444

Citation

Han, Qingmei, et al. "Coronavirus 2019-nCoV: a Brief Perspective From the Front Line." The Journal of Infection, vol. 80, no. 4, 2020, pp. 373-377.
Han Q, Lin Q, Jin S, et al. Coronavirus 2019-nCoV: A brief perspective from the front line. J Infect. 2020;80(4):373-377.
Han, Q., Lin, Q., Jin, S., & You, L. (2020). Coronavirus 2019-nCoV: A brief perspective from the front line. The Journal of Infection, 80(4), 373-377. https://doi.org/10.1016/j.jinf.2020.02.010
Han Q, et al. Coronavirus 2019-nCoV: a Brief Perspective From the Front Line. J Infect. 2020;80(4):373-377. PubMed PMID: 32109444.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Coronavirus 2019-nCoV: A brief perspective from the front line. AU - Han,Qingmei, AU - Lin,Qingqing, AU - Jin,Shenhe, AU - You,Liangshun, Y1 - 2020/02/25/ PY - 2020/02/09/received PY - 2020/02/11/accepted PY - 2020/2/29/pubmed PY - 2020/4/9/medline PY - 2020/2/29/entrez KW - 2019-nCoV KW - Epidemiology KW - Genomic KW - Therapeutic SP - 373 EP - 377 JF - The Journal of infection JO - J Infect VL - 80 IS - 4 N2 - A novel coronavirus, designated as 2019-nCoV, hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of China and multiple countries. As of 0:00 am February 9, 2020, a total of 37,287 cases have been confirmed infection of 2019-nCoV in China mainland, and 302 cases have also been cumulatively reported from 24 countries. According to the latest data, a total of 813 deaths occurred in China mainland, with the mortality reaching approximately 2.2%. At present, there is no vaccine or specific drugs for the human coronavirus. Therefore, it is critical to understand the nature of the virus and its clinical characteristics, in order to respond to the 2019-nCoV outbreak. Thus, the present study briefly but comprehensively summarizes the not much but timely reports on the 2019-nCoV. SN - 1532-2742 UR - https://www.unboundmedicine.com/medline/citation/32109444/Coronavirus_2019_nCoV:_A_brief_perspective_from_the_front_line_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0163-4453(20)30087-6 DB - PRIME DP - Unbound Medicine ER -